Cargando…
Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma
BRAF inhibitors target the BRAF-V600E/K mutated kinase, the driver mutation found in 50% of cutaneous melanoma. They give unprecedented anti-tumor responses but acquisition of resistance ultimately limits their clinical benefit. The master regulators driving the expression of resistance-genes remain...
Autores principales: | Corre, Sébastien, Tardif, Nina, Mouchet, Nicolas, Leclair, Héloïse M., Boussemart, Lise, Gautron, Arthur, Bachelot, Laura, Perrot, Anthony, Soshilov, Anatoly, Rogiers, Aljosja, Rambow, Florian, Dumontet, Erwan, Tarte, Karin, Bessede, Alban, Guillemin, Gilles J., Marine, Jean-Christophe, Denison, Michael S., Gilot, David, Galibert, Marie-Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235830/ https://www.ncbi.nlm.nih.gov/pubmed/30429474 http://dx.doi.org/10.1038/s41467-018-06951-2 |
Ejemplares similares
-
CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance
por: Gautron, Arthur, et al.
Publicado: (2021) -
Role of Flavonoids in the Prevention of AhR-Dependent Resistance During Treatment with BRAF Inhibitors
por: Leclair, Héloïse M., et al.
Publicado: (2020) -
p53 Requires the Stress Sensor USF1 to Direct Appropriate Cell Fate Decision
por: Bouafia, Amine, et al.
Publicado: (2014) -
The AhR‐SRC axis as a therapeutic vulnerability in BRAFi‐resistant melanoma
por: Paris, Anaïs, et al.
Publicado: (2022) -
Prophylactic and Therapeutic Effect of Kynurenine for Experimental Autoimmune Encephalomyelitis (EAE) Disease
por: Sundaram, Gayathri, et al.
Publicado: (2022)